Latest Articles
- The newer antimuscarinic drugs: Bladder control with less dry mouth
Tolterodine (Detrol) and extended-release oxybutynin (Ditropan XL) are replacing immediate-release oxybutynin, being better tolerated.
- Poor hypertension control: Let’s stop blaming the patients
Only 27% of people with hypertension are at goal blood pressure levels, according to government figures. Is it the fault of the patients—or their physicians?
Should exercise electrocardiography be a routine part of the periodic health physical?No, but it is warranted in patients with multiple risk factors if coronary artery disease is suspected.
- Acute ischemic stroke: Is there a role for hypothermia?
Preliminary trials suggest that therapeutic hypothermia is beneficial in acute stroke; larger trials are under way.
- A 74-year-old woman with hemodynamic complications of acute MI
A high suspicion is key to early diagnosis and prompt management of mechanical complications of acute MI. Advances in echocardiography have made it the key test.
- A 52-year-old man with sudden onset of a facial rash
Questions and answers on the visible signs of diseases.
Treating hyperglycemia in type 2 diabetes: New goals and strategiesA practical perspective on how to use the new oral drugs and insulins, alone and in combination.
- Follow the evidence—but don’t expect a straight path
The newest data on hormone replacement therapy remind us that evidence-based practice is not cookbook medicine.
- Choosing the most appropriate valve operation and prosthesis
Should the valve be repaired or replaced? And if replaced, which prosthesis is best?
Is there a relationship between hypertension and cognitive function in older adults?Yes, and there is some evidence that treating hypertension protects against cognitive decline later in life.